Cancer of Unknown Primary Site: Real Entity or Misdiagnosed Disease?

被引:15
|
作者
Alshareeda, Alaa T. [1 ]
Al-Sowayan, Batla S. [1 ]
Alkhani, Reem R. [2 ]
Aldosari, Sahar M. [3 ]
Al Subayyil, Abdullah M. [1 ]
Alghuwainem, Ayidah [1 ]
机构
[1] King Abdul Aziz Med City, Minist Natl Guard Hlth Affairs, King Abdullah Int Med Res Ctr, Stem Cells & Regenerat Med Unit,Cell Therapy & Ca, Riyadh 11426, Saudi Arabia
[2] Princess Nourah Bint Abdulrahman Univ, Hlth Sci Res Ctr, Res Dept, Riyadh, Saudi Arabia
[3] Prince Sultan Mil Med City, Cytogenet & Mol Genet, Riyadh, Saudi Arabia
来源
JOURNAL OF CANCER | 2020年 / 11卷 / 13期
关键词
Cancer of unknown primary; Immunohistochemistry; Genetic abnormality; Cancer Stem Cells; angiogenesis; CLINICAL-PRACTICE GUIDELINES; METASTATIC CARCINOMA; PRIMARY CUP; C-KIT; PRIMARY ORIGIN; PRIMARY TUMORS; EXPRESSION; TISSUE; IDENTIFICATION; MULTICENTER;
D O I
10.7150/jca.42880
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis is a late event in the progression of any tumour. However, invasive cancers are occasionally detected in the form of metastatic lesions without a clearly detectable primary tumour. Cancer of unknown primary site (CUP) is defined as a confirmed metastatic tumour, with unknown primary tumour site, despite the standardized diagnostic approach that includes clinical history, routine laboratory tests, and complete physical examination. Due to the lack of basic research on its primary causes, CUP is appropriately termed an 'orphan' cancer. Nevertheless, CUP accounts for 2-5% of diagnosed malignancies. To date, it is unclear whether CUP is an entity with primary dormancy as its hallmark or an entity with genetic abnormalities that cause it to manifest as a primary metastatic disease. In this review, we discuss different aspects of CUP, including its current diagnostic methods, angiogenesis effectors, relationship with cancer stem cells and current treatments.
引用
收藏
页码:3919 / 3931
页数:13
相关论文
共 50 条
  • [1] Metastatic angiosarcoma of unknown primary site misdiagnosed as tuberculosis
    Issakwisa, Mwakyula
    Mwakyusa, Ngwilo
    Torres, Liset
    Ngatunga, Cecilia
    Chaula, Baraka
    Maro, Haika
    Mboma, Lazaro
    Nguma, Irene
    Nqwata, Lamla
    Mujwahuzi, Leodegard
    CLINICAL CASE REPORTS, 2020, 8 (12): : 3017 - 3022
  • [2] Cancer of unknown primary site: still an entity, a biological mystery and a metastatic model
    Greco, F. Anthony
    NATURE REVIEWS CANCER, 2014, 14 (01) : 3 - 4
  • [3] Cancer of unknown primary site: still an entity, a biological mystery and a metastatic model
    F. Anthony Greco
    Nature Reviews Cancer, 2014, 14 : 3 - 4
  • [4] Cancer of Unknown Primary Site
    Morris, Gloria J.
    Greco, Frank A.
    Hainsworth, John D.
    Engstrom, Paul F.
    Scialla, Salvatore
    Jordan, W. Edward, III
    Thomas, Lisa C.
    SEMINARS IN ONCOLOGY, 2010, 37 (02) : 71 - 79
  • [5] CANCER OF UNKNOWN PRIMARY SITE
    ULTMANN, JE
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1991, 117 (06) : 505 - 509
  • [6] CANCER OF UNKNOWN PRIMARY SITE
    MUIR, C
    CANCER, 1995, 75 (01) : 353 - 356
  • [7] Cancer of unknown primary site
    Pavlidis, Nicholas
    Pentheroudakis, George
    LANCET, 2012, 379 (9824): : 1428 - 1435
  • [8] CANCER OF UNKNOWN PRIMARY SITE
    ROBINSON, B
    NEW ZEALAND MEDICAL JOURNAL, 1988, 101 (858) : 787 - 788
  • [9] CANCER OF UNKNOWN PRIMARY SITE
    SCHLAG, PM
    HUNERBEIN, M
    ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 1994, 83 (01) : 8 - 12
  • [10] Cancer of unknown primary site
    Gallagher, Chris J.
    Reznek, Rodney H.
    CLINICAL MEDICINE, 2008, 8 (04) : 451 - 454